Metastasis is a commonly used term in the malignant evaluation of cancer cells in which cancer cells gain the ability to invade neighboring tissues and distant secondary organs and eventually colonize these organs. Due to its incurability by surgical resection and tumor cells' resistance to chemotherapeutic agents, metastasis is estimated to be the primary cause of 90 percent of cancer-related mortality. Metastatic cells spread in a variety of ways, including hematogenous spread, lymphatic spread, and seeding into body cavities. Although the lymphatic spread of cancer cells is common in metastasis and is a prognostic factor, the hematogenous spread is the most common way in human tumors. Colorectal and ovarian cancers frequently exhibit seeding into body cavities. Several innovative minds across the world are trying to come up with solutions for this fatal malady. One such innovative organization is Mestastop Solutions.
Mestastop Solutions
Ambitious people never sleep. Mestastop Solutions is just another example of how ambition combined with talent can create something mind-boggling. Globally, in the year 2016, 9.6 million people died of cancer and most of those deaths were due to metastasis, i.e., the spread of the primary tumor to other parts of the body. Mestastop aims to make a difference in this life-threatening situation through a greater understanding of metastasis biology for both diagnostic and discovery purposes. The company’s vision is to be ‘the metastasis specialists’ and wishes to achieve this vision through creating a world-class R&D facility focused on metastasis and leveraging the unique strengths of being in the Indian subcontinent. Mestastop brings together a cross-functional team, trained in discovery, diagnostics, and AI, to learn more about Metastasis and possibly, help patients improve before it’s too late. Patients would be supported by the state-of-the-art infrastructure available in India’s best bioscience incubators working with the highest standards of data integrity. With a mission to create a common metastasis-directed proprietary platform, Mestastop intends to partner with biopharma to discover, develop, & re-purpose multiple metastasis targeted molecules.
Post a Comment